MYBPC3
MYBPC3 (myosin binding protein C3, also known as cMyBP-C, FHC and CMH4) encodes the cardiac isoform of myosin-binding protein C, a thick filament-associated protein of striated muscle. It is a key regulator of cardiac contraction and is frequently mutated in familial hypertrophic cardiomyopathy. Browse Assay Genie's current range of MYBPC3 research reagents below, or read on for the biology behind the target.
MYBPC3, the cardiac-type myosin-binding protein C (cMyBP-C), is a thick filament-associated protein found in the crossbridge region of the A bands of vertebrate striated muscle. In vitro it binds myosin heavy chain (MHC), F-actin and native thin filaments, and it modifies the activity of actin-activated myosin ATPase. The UniProt annotation notes that it may modulate muscle contraction or may instead play a more structural role. NCBI Gene describes it as a myosin-associated protein of the cross-bridge-bearing zone (C region) and a key regulator of cardiac contraction.
The MYBPC3 gene encodes the cardiac isoform of myosin-binding protein C, and according to the RefSeq summary it is expressed exclusively in heart muscle. This cardiac restriction distinguishes it from other myosin-binding protein C family members of striated muscle. The protein belongs to the immunoglobulin superfamily and the MyBP family, and HGNC places it in the I-set domain containing and myosin binding proteins gene groups. Researchers working with the MYBPC3 protein often study it alongside other sarcomeric components.
Mutations in the MYBPC3 gene are a frequent cause of familial hypertrophic cardiomyopathy, which explains the historical symbols FHC and CMH4 (cardiomyopathy, hypertrophic, 4). The previous HGNC name was myosin-binding protein C, cardiac. Mouse and rat orthologs are both named Mybpc3, which allows the protein to be studied in common rodent models of cardiac muscle biology.
MYBPC3 is a key regulator of cardiac contraction and modifies actin-activated myosin ATPase activity, making it central to studies of sarcomere function.
Mutations in MYBPC3 are a frequent cause of familial hypertrophic cardiomyopathy, so the gene and protein are widely studied in inherited heart disease.
As a thick filament-associated protein in the crossbridge region of the A band, MYBPC3 is relevant to how myosin and actin filaments are organised.
Because MYBPC3 is expressed exclusively in heart muscle, it serves as a marker for investigating cardiac tissue and cardiac-specific biology.
MYBPC3 is a thick filament-associated protein in the crossbridge region of striated muscle A bands. In vitro it binds MHC, F-actin and native thin filaments and modifies actin-activated myosin ATPase activity. It may modulate contraction or play a more structural role, and it is a key regulator of cardiac contraction.
MYBPC3 is also called cMyBP-C, FHC and CMH4. The UniProt protein name is myosin-binding protein C, cardiac-type, and the previous HGNC name was myosin-binding protein C, cardiac. The gene encodes the cardiac isoform of myosin-binding protein C.
Mutations in MYBPC3 are a frequent cause of familial hypertrophic cardiomyopathy. Orthologs exist in mouse and rat, both named Mybpc3. Check the datasheet of any product for its validated reactivity before using it in rodent or other species samples.
Other myosin-binding proteins, sarcomeric components and cardiac muscle markers with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q14896; product specifications from Assay Genie datasheets.